Imatinib-induced erythroderma.
Mathew
Teena
T
Chandrashekar
Laxmisha
L
Pulimood
Susanne
S
Srivastava
Alok
A
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate